EP03.01-003 Clinical Features and Molecular Profile of Advanced Non-small Cell Lung Cancer in Latin America: LATINO Lung (LACOG 0116)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
Fernando C. Maluf, Fabio A. Schutz, Eduardo H. Cronemberger, Murilo de A. Luz, Suelen P. S. Martins, David Q. B. Muniz, Diogo A. Bastos, Flavio M. Cárcano, Oren Smaletz, Andrey Soares, Fábio A. Peixoto, Andrea J. Gomes, Felipe M. Cruz, Fabio A. Franke, Daniel Herchenhorn, Telma M. dos Santos, Vanessa de C. Fabricio, Rosemarie Gidekel, Gustavo Werutsky, Rafaela G. de Jesus, Vinicius C. Souza, André P. Fay DOI: https://doi.org/10.1016/j.ejca.2021.08.032 Full link: https://www.sciencedirect.com/science/article/pii/S0959804921005591
Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study – LACOG 0619
Camilla Yamada, Carolina Vasques, Rodrigo Coutinho, Marcos Maldaun, Clarissa Baldotto, Fabiana Viola, Fernando Maluf, Vanessa Santos, Carolina Pessoa, Patrícia Pacheco, Danielli Matias, Daniela Oliveira, Fernanda Peria, Rafaela de Jesus, Taiane Rebelatto, Suzana Malheiros DOI: https://doi.org/10.1093/neuonc/noab196.340 Full link: https://academic.oup.com/neuro-oncology/article-abstract/23/Supplement_6/vi86/6426546
Memo inOncology SPECIAL ISSUE congress report ASCO 2021- Lung Cancer is now available!
This report highlights immunotherapeutic standards in early-stage lung cancer. Moreover, strategies against sensitizing and resistance-mediating EGFR mutations as well as current perspectives regarding KRAS, MET, ROS1 and HER2 mutations are covered. Furthermore, immunotherapies and immunosupportive mechansims via e.g. anti-angiogenesis are addressed. Last but not least, this special issue includes a section about new vistas for patients with SCLC and expert interviews regarding resistance as one of the biggest challenges with targeted therapies. As an additional feature, you will find expert video interviews with Martin Reck, Luis Paz-Ares, David T. Cooke, Donald Harvey, and Ferdinandos Skoulidis on different conference highlights on our website. Download the full report
Innovation in Breast Cancer Symposium – Lisbon edition 2021
O IBC Lisbon 2021 trata-se um evento com um programa científico internacional, com a duração de dois dias e que visa fornecer informações de última geração sobre o câncer de mama, fomentando o equilíbrio entre a investigação clínica, translacional e básica, bem como, proporcionar um fórum de interação, discussão e aprendizagem para médicos e farmacêuticos hospitalares e outros especialistas (profissionais de saúde e investigadores) com especial interesse no câncer de mama. Data: de 14/10/2021 a 15/10/2021Local: OnlineEndereço: Lisboa, PortugalInvestimento/Taxa de Inscrição: 350€ (IVA incluído)Inscrições: http://www.innovationinbreastcancer.com/lisbon
Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review
André G. Gouveia, Dominic C. W. Chan, Peter J. Hoskin, Gustavo N. Marta, Fabio Trippa, Ernesto Maranzano, Edward Chow, Mauricio F. SilvaDOI: https://doi.org/10.1016/j.radonc.2021.07.022 Full link: https://www.sciencedirect.com/science/article/pii/S0167814021066652?dgcid=coauthor
V International Congress GU Review 2021
GU Review is in its 5th edition, and has become a long awaited event for oncologists. Annually, the scientific program is developed with the most actual in the treatment and diagnosis of genitourinary neoplasms. This year the congress will be broadcast online, and will present modules such as Kidney, Prostate, Penile and Bladder Cancer, bringing important national and international experts to discuss relevant topics in these areas. Subscribe now: https://rvmais.iweventos.com.br/gu-review2021
Ragma 21 – 14° GEICAM Annual Review of Advances in Breast Cancer
In this annual multidisciplinary meeting, attended by all professionals related to breast cancer, a comprehensive review of the advances in research, diagnosis and treatment of this disease is carried out.The main objective of this event is to become the reference for all those interested in knowing in an independent, complete and critical way the advances in breast cancer. The event will take place on June 17th and 18th in a virtual format. Sign up on the website:: https://www.ragmageicam.org/ Check out the event schedule
Sequential therapies for advanced urothelial cancer: Hope meets new challenges
Daniel Herchenhorn, Vinicius Freire, Thamires Oliveira, Juliana Tarouquella - Crit Rev Oncol Hematol. 2021 April
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial
Sibylle Loibl, Frederik Marmé, Miguel Martin, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole McCarthy, Mireia Melé Olivé, Karen Gelmon, José García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, Maria Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Gunter von Minckwitz - Journal of Clinical Oncology. April 01, 2021.